Vaxart: Too Early To Dismiss This COVID-19 Vaccine Opportunity (NASDAQ:VXRT)
Investment Thesis The stock prices of biotechs developing vaccine solutions for COVID-19 have declined markedly over the past couple of weeks, despite the need for a coronavirus cure being greater than ever. Performance of selected…